Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

European Agency for the Evaluation of Medicinal Products

CPMP Note for Guidance on the Investigation of Bioavailability and bioequivalence (CPMP/EWP/QWP/ 1401/98) The European Agency for the Evaluation of Medicinal Products, 2001. [Pg.527]

Includes information on the European Agency for the Evaluation of Medicinal Products. [Pg.982]

The EU Directive 92/18/EEC [122] introduced for the first time the requirement for an ERA, as a prerequisite to obtain marketing authorization for veterinary pharmaceuticals. For this purpose, the European Agency for the Evaluation of Medicinal Products (EMEA) published a Note for Guidance where guidelines to assess the environmental risk of veterinary medicinal products are established [123]. [Pg.231]

See other pages where European Agency for the Evaluation of Medicinal Products is mentioned: [Pg.300]    [Pg.220]    [Pg.97]    [Pg.182]    [Pg.338]    [Pg.982]    [Pg.7]    [Pg.327]    [Pg.201]    [Pg.222]    [Pg.436]   
See also in sourсe #XX -- [ Pg.347 ]

See also in sourсe #XX -- [ Pg.3 , Pg.14 , Pg.82 , Pg.157 , Pg.158 ]



SEARCH



European Agency for Evaluation

European Agency for Evaluation of Medicinal Products

European Agency for the Evaluation

European Agency for the Evaluation Medicinal Products

European Medicinal Evaluation Agency

European Medicines

European Medicines Evaluation

European Medicines Evaluation Agency

European Medicines Evaluation Agency Products

Evaluation of medicinal products

Medicines products

Product evaluation

© 2024 chempedia.info